MC
MED icon

Matisse Capital’s Medifast MED Stock Holding History

Matisse Capital’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,950
Closed -$221K – 207
2023
Q3 		$221K Hold
2,950
– – 0.16% 150
2023
Q2 		$272K Hold
2,950
– – 0.17% 145
2023
Q1 		$306K Hold
2,950
– – 0.2% 142
2022
Q4 		$340K Buy
+2,950
New +$344K 0.3% 90
2022
Q3 		– Sell
-2,800
Closed -$505K – 112
2022
Q2 		$505K Hold
2,800
– – 0.48% 66
2022
Q1 		$478K Hold
2,800
– – 0.44% 63
2021
Q4 		$586K Buy
2,800
+100
+4% +$20.7K 0.41% 63
2021
Q3 		$520K Buy
2,700
+550
+26% +$135K 0.19% 89
2021
Q2 		$608K Sell
2,150
-150
-7% -$40.6K 0.19% 89
2021
Q1 		$487K Sell
2,300
-150
-6% -$35.9K 0.14% 114
2020
Q4 		$481K Sell
2,450
-150
-6% -$26.5K 0.15% 104
2020
Q3 		$428K Hold
2,600
– – 0.17% 94
2020
Q2 		$361K Sell
2,600
-1,433
-36% -$132K 0.12% 108
2020
Q1 		$252K Buy
4,033
+300
+8% +$27.3K 0.1% 148
2019
Q4 		$409K Buy
3,733
+400
+12% +$38.7K 0.29% 69
2019
Q3 		$345K Buy
3,333
+200
+6% +$21.5K 0.42% 60
2019
Q2 		$402K Buy
3,133
+783
+33% +$109K 0.51% 48
2019
Q1 		$300K Buy
2,350
+150
+7% +$19K 0.36% 64
2018
Q4 		$275K Buy
2,200
+500
+29% +$85.5K 0.35% 70
2018
Q3 		$377K Sell
1,700
-50
-3% -$10.1K 0.34% 73
2018
Q2 		$280K Buy
+1,750
New +$224K 0.22% 93
2016
Q2 		– Sell
-8,183
Closed -$247K – 98
2016
Q1 		$247K Buy
8,183
+73
+0.9% +$2.13K 0.13% 84
2015
Q4 		$246K Buy
+8,110
New +$242K 0.12% 90

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Matisse Capital's MED Position: Q4 2023 in Review

Matisse Capital sold out of Medifast (MED) in Q4 2023, closing a stake of 2,950 shares — an estimated $221K sold.

Matisse Capital first reported a position in MED in Q4 2015 and held it in 23 quarters. The position peaked at $608K in Q2 2021. 216 funds tracked by Wall St. Rank hold MED as of Q4 2023.

  • Matisse Capital reported no remaining Medifast position as of Q4 2023 after selling out during the quarter.
  • Matisse Capital sold 2,950 Medifast shares in Q4 2023, an estimated $221K.
  • Matisse Capital first reported a position in Medifast in Q4 2015 and held it in 23 quarters.
  • Matisse Capital's Medifast position peaked at $608K in Q2 2021.
  • 216 funds tracked by Wall St. Rank held Medifast as of Q4 2023.

Based on Matisse Capital's 13F filing for Q4 2023, filed 8 Feb 2024.